Jiangsu GDK Biotechnology Co Ltd (688670) — Capital Reinvestment Ratio
Jiangsu GDK Biotechnology Co Ltd (688670) has a Capital Reinvestment Ratio of 0.67x as of December 2023, meaning it reinvests 1% of its operating cash flow (CN¥80.90 Million) in capital expenditures (CN¥54.00 Million). See 688670 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu GDK Biotechnology Co Ltd Capital Reinvestment Ratio (2020–2023)
This chart tracks Jiangsu GDK Biotechnology Co Ltd's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Jiangsu GDK Biotechnology Co Ltd (2020–2023)
Year-by-year Capital Reinvestment Ratio for Jiangsu GDK Biotechnology Co Ltd from 2020 to 2023. For live market cap and broader valuation context, see Jiangsu GDK Biotechnology Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.67x | CN¥80.90 Million | CN¥54.00 Million | ▼ -84.7% |
| 2022 | 4.36x | CN¥38.60 Million | CN¥168.18 Million | ▲ +17.2% |
| 2021 | 3.72x | CN¥103.93 Million | CN¥386.39 Million | ▲ +897.2% |
| 2020 | 0.37x | CN¥109.46 Million | CN¥40.81 Million | — |